Czechia, March 10 -- Czechia based Fresenius Kabi s.r.o. has secured contract from Fakultni nemocnice u sv. Anny v Brne for Pharmaceutical products J01CR05 PIPERACILIN A INHIBITOR BETA-LAKTAMASY. The value of the contract is worth 412300000 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....